| Cullinan Therapeutics, Inc. | CGEM | 7.65M | $79.2M | 9.1% | — | Held |
| Madrigal Pharmaceuticals, Inc. | MDGL | 96.8K | $56.4M | 6.4% | — | Held |
| Liquidia Corp | LQDA | 1.4M | $48.3M | 5.5% | — | Held |
| Trevi Therapeutics, Inc. | TRVI | 3.29M | $41.2M | 4.7% | — | Held |
| Edgewise Therapeutics, Inc. | EWTX | 1.66M | $41.1M | 4.7% | — | Held |
| Revolution Medicines Inc | — | 505.7K | $40.3M | 4.6% | — | Held |
| Agios Pharmaceuticals, Inc. | AGIO | 1.3M | $35.5M | 4.1% | — | Held |
| Uniqure Nv | — | 1.38M | $33.1M | 3.8% | — | Held |
| Ptc Therapeutics, Inc. | PTCT | 430K | $32.7M | 3.7% | — | Held |
| Syndax Pharmaceuticals Inc | SNDX | 1.34M | $28.1M | 3.2% | — | Held |
| Dyne Therapeutics, Inc. | DYN | 1.41M | $27.5M | 3.1% | — | Held |
| Tarsus Pharmaceuticals, Inc. | TARS | 328.9K | $26.9M | 3.1% | — | Held |
| Stoke Therapeutics, Inc. | STOK | 770.3K | $24.4M | 2.8% | — | Held |
| Alumis Inc. | ALMS | 2.4M | $23.4M | 2.7% | — | Held |
| UroGen Pharma Ltd. | URGN | 941.4K | $22M | 2.5% | — | Held |
| Xenon Pharmaceuticals Inc. | XENE | 485.6K | $21.8M | 2.5% | — | Held |
| Palvella Therapeutics Inc Ne | — | 205.7K | $21.5M | 2.5% | — | Held |
| Natera, Inc. | NTRA | 93.6K | $21.4M | 2.5% | — | Held |
| Corvus Pharmaceuticals, Inc. | CRVS | 2.74M | $21.1M | 2.4% | — | Held |
| Dbv Technologies S A | — | 996.8K | $19.1M | 2.2% | — | Held |
| Relay Therapeutics, Inc. | RLAY | 2.23M | $18.9M | 2.2% | — | Held |
| Monte Rosa Therapeutics, Inc. | GLUE | 1.17M | $18.4M | 2.1% | — | Held |
| Bright Minds Biosciences Inc. | DRUG | 230.1K | $18M | 2.1% | — | Held |
| Protagonist Therapeutics, Inc | PTGX | 199.5K | $17.4M | 2.0% | — | Held |
| Engene Holdings Inc | — | 1.84M | $16.6M | 1.9% | — | Held |
| Context Therapeutics Inc. | CNTX | 10.7M | $15.7M | 1.8% | — | Held |
| Arcutis Biotherapeutics, Inc. | ARQT | 531.2K | $15.4M | 1.8% | — | Held |
| Ventyx Biosciences Inc | — | 1.64M | $14.8M | 1.7% | — | Held |
| Oric Pharmaceuticals, Inc. | ORIC | 1.8M | $14.7M | 1.7% | — | Held |
| Belite Bio, Inc | BLTE | 87.8K | $14M | 1.6% | — | Held |
| Rapt Therapeutics Inc | — | 397.9K | $13.5M | 1.5% | — | Held |
| Climb Bio, Inc. | CLYM | 2.67M | $10.7M | 1.2% | — | Held |
| Abivax Sa | — | 56.3K | $7.59M | 0.9% | — | Held |
| Rocket Pharmaceuticals Inc | — | 1.59M | $5.57M | 0.6% | — | Held |
| Maze Therapeutics, Inc. | MAZE | 81.1K | $3.36M | 0.4% | — | Held |
| Evommune, Inc. | EVMN | 113K | $1.93M | 0.2% | — | Held |
| Sarepta Therapeutics, Inc. | SRPT | 70K | $1.51M | 0.2% | — | Held |
| Werewolf Therapeutics, Inc. | HOWL | 1.39M | $883.5K | 0.1% | — | Held |